Millennium Management LLC Lowers Holdings in Relx Plc (NYSE:RELX)

Millennium Management LLC reduced its position in Relx Plc (NYSE:RELX) by 46.0% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 181,956 shares of the technology company’s stock after selling 155,270 shares during the quarter. Millennium Management LLC’s holdings in Relx were worth $8,264,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. LGT Group Foundation purchased a new stake in shares of Relx in the fourth quarter valued at about $257,000. Paradigm Asset Management Co. LLC boosted its holdings in Relx by 17.1% in the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock valued at $3,706,000 after purchasing an additional 11,900 shares in the last quarter. Smartleaf Asset Management LLC increased its position in Relx by 120.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company’s stock worth $548,000 after purchasing an additional 6,588 shares during the period. Merit Financial Group LLC acquired a new position in Relx during the 4th quarter worth approximately $301,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Relx by 19.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company’s stock worth $6,517,000 after buying an additional 23,183 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Relx Trading Up 0.9%

Relx stock opened at $55.45 on Monday. The stock has a 50-day moving average price of $51.79 and a 200 day moving average price of $49.19. Relx Plc has a 52 week low of $43.28 and a 52 week high of $55.68. The stock has a market cap of $102.36 billion, a PE ratio of 29.81, a P/E/G ratio of 2.73 and a beta of 0.86. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Analyst Ratings Changes

A number of analysts recently weighed in on RELX shares. Morgan Stanley restated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group began coverage on shares of Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Finally, Wall Street Zen downgraded shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.